FDA 483 - Radix Laboratories Inc - July 25, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Radix Laboratories Inc, an animal drug manufacturer in Eau Claire, WI, was cited for significant deficiencies during an FDA inspection. Observations included releasing drug products before complete testing, failing to follow procedures to prevent objectionable microorganisms in non-sterile products, and inadequate quality control unit procedures regarding document control. These issues indicate a lack of adherence to quality assurance and manufacturing process controls.
ID · d0e62ba8-a3ed-4710-b3c4-53719321cbb7